MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-18-2025
Helius Medical Technologies General and Administrative Expenses 2011-2026 | HSDT
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Helius Medical Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.27 M | 10.6 M | 12.2 M | - | - | 17.2 M | 8.47 M | 5.67 M | 4.26 M | 896 K | 4.27 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.2 M | 896 K | 8.1 M |
Quarterly General and Administrative Expenses Helius Medical Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.65 M | 2.45 M | 2.99 M | - | 2.86 M | 2.46 M | 2.63 M | - | 2.2 M | 2.57 M | 2.87 M | - | 3.39 M | 2.46 M | 2.82 M | - | 2.86 M | 4.74 M | 2.2 M | - | 2.37 M | 2.39 M | 2.86 M | - | 4.29 M | 3.84 M | 4.58 M | - | 2.58 M | 8.89 M | 2.16 M | - | 2.17 M | 1.68 M | 2.01 M | - | 1.98 M | 1.45 M | 1.93 M | 30.4 K | 724 K | 2.19 M | - | 45.5 K | 45.5 K | 83.7 K | 21.4 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.89 M | 21.4 K | 2.5 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
1.76 B | - | - | $ 14 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
814 M | $ 295.96 | 1.28 % | $ 8.35 B | USA |
 |
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 12.65 | - | $ 1.71 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.59 | 0.37 % | $ 36.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | - | - | $ 132 M |  France |
 |
Bruker Corporation
BRKR
|
894 M | - | - | $ 5.88 K | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 64.61 | 1.25 % | $ 95.6 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 10.46 | 0.77 % | $ 296 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
39.3 M | $ 25.71 | 1.98 % | $ 217 M | USA |
 |
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
1.18 B | $ 94.55 | -0.41 % | $ 12.8 B | USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.86 | 9.46 % | $ 1.03 B | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
67.4 M | $ 6.2 | -2.21 % | $ 165 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.04 | 0.97 % | $ 17.6 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 10.99 | 1.01 % | $ 394 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 17.85 | -0.06 % | $ 419 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 56.64 | -0.33 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 39.44 | -0.73 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 65.14 | 0.23 % | $ 3.55 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 87.94 | -0.78 % | $ 3.05 B | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 18.77 | 0.05 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |
 |
LENSAR
LNSR
|
45.2 M | $ 6.25 | 3.48 % | $ 74.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 78.2 | - | $ 45.7 B | USA |
 |
Smith & Nephew plc
SNN
|
2.72 B | $ 34.22 | -0.38 % | $ 23.8 B | Britain |